Dr. Vokes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1400 Holcombe Blvd
Houston, TX 77030Phone+1 877-632-6789
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2016 - 2019- Brigham and Women's HospitalResidency, Internal Medicine, 2013 - 2016
Harvard Medical SchoolClass of 2013
Certifications & Licensure
FL State Medical License 2021 - Present
GA State Medical License 2022 - 2026
TX State Medical License 2020 - 2026
AL State Medical License 2022 - 2025
AZ State Medical License 2022 - 2025
LA State Medical License 2022 - 2025
MS State Medical License 2022 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
- Join now to see all
Publications & Presentations
PubMed
- Impact of co-mutations and transcriptional signatures in non-small cell lung cancer patients treated with adagrasib in the KRYSTAL-1 trial.Marcelo V Negrao, Alvaro G Paula, David Molkentine, Laura Hover, Monique Nilsson
Clinical Cancer Research. 2025-01-13 - Brief Report: Clinical Characteristics and Outcomes of Patients With Thoracic SMARCA4-Deficient Undifferentiated Tumors.Alissa J Cooper, Andrea Arfe, Biagio Ricciuti, Andréanne Gagné, Lynette M Sholl
JTO Clinical and Research Reports. 2025-01-01 - 1 citationsHigh peripheral T cell diversity is associated with lower risk of toxicity and superior response to dual immune checkpoint inhibitor therapy in patients with metastati...Mehmet Altan, Ruoxing Li, Ziyi Li, Runzhe Chen, Ajay Sheshadri
Journal for Immunotherapy of Cancer. 2024-12-25
Journal Articles
- Genomic Correlates of Response to Immune Checkpoint Blockade in Microsatellite-Stable Solid TumorsJeffrey A Engelman, David A Barbie, Nicole G Chau, Glenn J Hanna, Natalie I Vokes, Sabina Signoretti, Pasi A Janne, Robert I Haddad, Lynette M Sholl, Rizwan Haq, Peter..., Nature
Lectures
- Distinct immunogenomic properties of melanomas with stable disease as best response to immune checkpoint blockade (ICB).2019 ASCO Annual Meeting - 6/1/2019
- Genomic correlates of response to immune checkpoint blockade in microsatellite stable solid tumors.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Press Mentions
Integrative Molecular Characterization of Sarcomatoid and Rhabdoid Renal Cell CarcinomaFebruary 5th, 2021- Integrated Molecular Drivers Coordinate Biological and Clinical States in MelanomaNovember 23rd, 2020
Damon Runyon Announces Recipients of Physician-Scientist Training AwardMay 15th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
